@article{article, title  = {{The cost-effectiveness of belimumab and voclosporin for patients with Lupus Nephritis in the United States}},

 publisher = {{American Society of Nephrology (ASN)}},

 url = {{https://eprints.whiterose.ac.uk/id/eprint/184882 }},

 year = {{2022}},

 month = {{3}},

 author = {{Mandrik O and Fotheringham J and Ren S and Tice JA and Chapman RH and Stevenson MD and Pearson SD and Herron-Smith S and Agboola F and Thokala P}},

 doi = {{10.2215/cjn.13030921}},

 volume = {{17}},

 journal = {{Clinical Journal of the American Society of Nephrology}},

 issue = {{3}},

 pages = {{385-394}},

 note = {{Accessed on 2024/12/26}}}